Relapsed or progressive multiple myeloma

Pomalidomide prolongs survival in refractory multiple myeloma patients

Carfilzomib plus melphalanprednisone in elderly patients with newly diagnosed multiple myeloma

Rituximab for b-cell lymphoma and EHA overview

Highlights from EHA 2013

Second line treatment of multiple myeloma with melphalan prednisone and lenalidomide

Challenges facing haematologists treating acute myeloid leukaemia

JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms

Cyclophosphamide lenalidomide and dexamethasone in newly diagnosed myeloma

Addition of obinutuzumab or rituximab to chlorambucil improves outcomes for chronic lymphocytic leukaemia

Long-term outcomes with ruxolitinib and best available therapy for the treatment of myelofibrosis

Strategies to maintain remission in high risk CD19 lymphoid malignancies